These sales are too small in both absolute and relative terms to convey any bearish signal. They are likely routine portfolio diversification or tax-related transactions. Monitor for any larger insider purchases or material changes in insider ownership percentages in future Form 4 filings.
Price Chart
Executive Summary
Three top executives (CEO, CMO, CCO) at Dyne Therapeutics sold a combined ~$68K in shares on June 16, 2026, the same day the company announced a $50M draw on its expanded $400M Hercules Capital debt facility. The dollar amount is negligible — ~0.002% of the company's $3.0B market cap — making this a routine, non-informative insider sale cluster with no actionable signal.
Key Financial Metrics
Key Facts
- CEO John Cox sold 2,683 shares for ~$49K at $18.33/share on June 16.
- CMO Douglas Kerr sold 887 shares for ~$16K at $18.33/share.
- CCO Johanna Friedl-Naderer sold 145 shares for ~$3K at $18.33/share.
- Total insider sales of $68K represent ~0.0023% of DYN's $3.0B market cap.
- The sales occurred on the same day as a $50M draw under the company's expanded credit facility (8-K filed June 17).
Financial Impact
Negligible — total insider sales of ~$68K, less than 0.01% of market cap.
Risk Factors
- Dilution risk from the expanded debt facility's conversion features (if any).
- Possible future insider selling if executives accelerate liquidation ahead of data readouts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DYN-1781727045957 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access